Coty (COTY) Valuation Declined While Pnc Financial Services Group Has Trimmed Stake; As Momenta Pharmaceuticals (MNTA) Shares Rose, Sector Gamma As Lowered Position

May 20, 2018 - By Dolores Ford

Coty Inc. (NYSE:COTY) Logo

Pnc Financial Services Group Inc decreased its stake in Coty Inc (COTY) by 58.09% based on its latest 2017Q4 regulatory filing with the SEC. Pnc Financial Services Group Inc sold 39,630 shares as the company’s stock declined 8.23% with the market. The institutional investor held 28,592 shares of the package goods and cosmetics company at the end of 2017Q4, valued at $571,000, down from 68,222 at the end of the previous reported quarter. Pnc Financial Services Group Inc who had been investing in Coty Inc for a number of months, seems to be less bullish one the $10.51B market cap company. The stock decreased 1.27% or $0.18 during the last trading session, reaching $14. About 9.26 million shares traded or 82.43% up from the average. Coty Inc. (NYSE:COTY) has risen 0.16% since May 20, 2017 and is uptrending. It has underperformed by 11.39% the S&P500.

Sector Gamma As decreased its stake in Momenta Pharmaceuticals Inc (MNTA) by 14.07% based on its latest 2017Q4 regulatory filing with the SEC. Sector Gamma As sold 45,031 shares as the company’s stock rose 28.25% while stock markets declined. The institutional investor held 275,024 shares of the health care company at the end of 2017Q4, valued at $3.84M, down from 320,055 at the end of the previous reported quarter. Sector Gamma As who had been investing in Momenta Pharmaceuticals Inc for a number of months, seems to be less bullish one the $1.81B market cap company. The stock increased 1.96% or $0.45 during the last trading session, reaching $23.4. About 342,812 shares traded. Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has risen 23.66% since May 20, 2017 and is uptrending. It has outperformed by 12.11% the S&P500.

Investors sentiment decreased to 0.95 in Q4 2017. Its down 0.22, from 1.17 in 2017Q3. It dropped, as 29 investors sold COTY shares while 112 reduced holdings. 42 funds opened positions while 92 raised stakes. 499.23 million shares or 2.30% less from 510.97 million shares in 2017Q3 were reported. Westpac Bk Corp holds 0.43% of its portfolio in Coty Inc. (NYSE:COTY) for 956,245 shares. Sg Americas Llc has 90,515 shares. Parthenon Limited Liability reported 104,874 shares. Wellington Mngmt Group Llp stated it has 44.61M shares. Barclays Plc stated it has 0.01% in Coty Inc. (NYSE:COTY). Andra Ap owns 595,289 shares. Zurcher Kantonalbank (Zurich Cantonalbank) has 0.02% invested in Coty Inc. (NYSE:COTY). 2,754 are owned by Whittier Tru Of Nevada Inc. Caisse De Depot Et Placement Du Quebec has invested 0% of its portfolio in Coty Inc. (NYSE:COTY). Spears Abacus Advsr Ltd Liability Corporation has 17,560 shares for 0.04% of their portfolio. Massachusetts Fincl Co Ma owns 0.88% invested in Coty Inc. (NYSE:COTY) for 105.24M shares. Amer Interest Grp Inc owns 161,572 shares. Oz Mngmt Lp has invested 0.75% in Coty Inc. (NYSE:COTY). Sumitomo Mitsui holds 1.45 million shares or 0.04% of its portfolio. Dynamo Internacional Gestao De Recursos Ltda invested in 911,473 shares or 2.63% of the stock.

More recent Coty Inc. (NYSE:COTY) news were published by: Seekingalpha.com which released: “Coty positive on earnings beat” on May 09, 2018. Also Benzinga.com published the news titled: “Deutsche Bank: 4 Reasons Why Coty’s Stock Is No Longer Attractive” on May 13, 2018. Seekingalpha.com‘s news article titled: “Coty – Smells Bad” with publication date: May 13, 2018 was also an interesting one.

Among 16 analysts covering Coty (NYSE:COTY), 5 have Buy rating, 1 Sell and 10 Hold. Therefore 31% are positive. Coty had 56 analyst reports since July 21, 2015 according to SRatingsIntel. Berenberg upgraded the stock to “Hold” rating in Friday, November 18 report. The firm earned “Buy” rating on Friday, June 23 by Stifel Nicolaus. The firm has “Hold” rating given on Friday, August 14 by Piper Jaffray. The firm has “Buy” rating by BMO Capital Markets given on Thursday, February 8. The rating was maintained by DA Davidson on Friday, November 10 with “Neutral”. The stock has “Neutral” rating by Sterne Agee CRT on Tuesday, July 21. The firm has “Neutral” rating given on Thursday, August 25 by Citigroup. The rating was maintained by BMO Capital Markets with “Buy” on Wednesday, April 5. JP Morgan maintained the shares of COTY in report on Monday, February 12 with “Underweight” rating. The firm has “Hold” rating by Jefferies given on Wednesday, August 23.

Since February 12, 2018, it had 2 buys, and 0 sales for $84.69 million activity. Singer Robert S had bought 15,000 shares worth $211,770 on Friday, May 11.

Analysts await Coty Inc. (NYSE:COTY) to report earnings on August, 28. COTY’s profit will be $105.08 million for 25.00 P/E if the $0.14 EPS becomes a reality. After $0.13 actual EPS reported by Coty Inc. for the previous quarter, Wall Street now forecasts 7.69% EPS growth.

Pnc Financial Services Group Inc, which manages about $103.04B US Long portfolio, upped its stake in Motorola Solutions Inc (NYSE:MSI) by 4,401 shares to 84,278 shares, valued at $7.61 million in 2017Q4, according to the filing. It also increased its holding in Ishares Tr (IBB) by 443,499 shares in the quarter, for a total of 671,253 shares, and has risen its stake in Vanguard Specialized Funds (VIG).

Analysts await Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) to report earnings on August, 1. They expect $-0.36 earnings per share, up 28.00% or $0.14 from last year’s $-0.5 per share. After $-0.63 actual earnings per share reported by Momenta Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -42.86% EPS growth.

Since December 13, 2017, it had 0 insider purchases, and 24 sales for $4.67 million activity. $301,050 worth of stock was sold by WHEELER CRAIG A on Monday, February 12. The insider Leicher Bruce sold $75,333. 3,972 shares were sold by Storer Scott M, worth $60,216. $75,942 worth of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) was sold by Kaundinya Ganesh Venkataraman. 15,089 shares were sold by KWON YOUNG, worth $315,360.

More notable recent Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) news were published by: Fool.com which released: “Momenta Pharmaceuticals Contemplates Its Future” on May 15, 2018, also Nasdaq.com with their article: “Momenta Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Corporate Update” published on May 08, 2018, Benzinga.com published: “Benzinga’s Daily Biotech Pulse: AstraZeneca’s Q1, Novartis-Amgen Migraine Drug Approved” on May 18, 2018. More interesting news about Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) were released by: Nasdaq.com and their article: “Momenta Pharmaceuticals to Webcast Presentation at the Bank of America Merrill Lynch Health Care Conference 2018” published on May 10, 2018 as well as Nasdaq.com‘s news article titled: “Momenta Pharmaceuticals Announces Date of First Quarter 2018 Financial Results Conference Call and Webcast” with publication date: May 01, 2018.

Among 12 analysts covering Momenta Pharmaceuticals (NASDAQ:MNTA), 5 have Buy rating, 2 Sell and 5 Hold. Therefore 42% are positive. Momenta Pharmaceuticals had 29 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Hold” rating given on Tuesday, January 30 by Stifel Nicolaus. The rating was maintained by Leerink Swann on Tuesday, October 13 with “Outperform”. Barclays Capital upgraded the shares of MNTA in report on Tuesday, October 11 to “Overweight” rating. The stock of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) has “Overweight” rating given on Tuesday, January 31 by Barclays Capital. The stock of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) earned “Mkt Perform” rating by Leerink Swann on Wednesday, February 22. Cowen & Co maintained Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) rating on Tuesday, October 31. Cowen & Co has “Hold” rating and $15.0 target. As per Wednesday, August 2, the company rating was maintained by Stifel Nicolaus. The firm has “Sell” rating by Maxim Group given on Wednesday, September 7. The rating was initiated by Aegis Capital with “Hold” on Tuesday, November 22. The stock of Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) earned “Equal-Weight” rating by Barclays Capital on Monday, May 22.

Investors sentiment decreased to 1.45 in Q4 2017. Its down 0.28, from 1.73 in 2017Q3. It fall, as 19 investors sold MNTA shares while 36 reduced holdings. 23 funds opened positions while 57 raised stakes. 71.96 million shares or 2.47% more from 70.23 million shares in 2017Q3 were reported. Citigroup Inc owns 0% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) for 66,687 shares. State Of Tennessee Treasury Department, a Tennessee-based fund reported 60,057 shares. Axa reported 0% of its portfolio in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Amica Pension Fund Board Of Trustees stated it has 72,382 shares or 0.12% of all its holdings. 11,408 were accumulated by Landscape Cap Management Limited Company. D E Shaw & Incorporated invested in 1.74M shares or 0.03% of the stock. Teachers Retirement System Of The State Of Kentucky holds 0% or 15,700 shares. Voya Invest Mgmt Ltd Company, a Georgia-based fund reported 56,445 shares. State Common Retirement Fund invested in 274,737 shares or 0% of the stock. Moreover, Dekabank Deutsche Girozentrale has 0% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). Prudential Fincl owns 126,522 shares or 0% of their US portfolio. Sei has invested 0% in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA). 202,330 were reported by Aqr Cap Ltd Liability Co. Kbc Gp Nv holds 0.01% or 101,844 shares in its portfolio. Credit Suisse Ag has 0% invested in Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA).

Sector Gamma As, which manages about $594.94M US Long portfolio, upped its stake in Boston Scientific Corp (NYSE:BSX) by 232,000 shares to 1.70 million shares, valued at $42.17M in 2017Q4, according to the filing. It also increased its holding in Radius Health Inc (NASDAQ:RDUS) by 13,000 shares in the quarter, for a total of 52,173 shares, and has risen its stake in Cigna Corporation (NYSE:CI).

Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Dolores Ford

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: